CMS sheds light on the future of medical schemes and NHI in South Africa
A recent interview with Dr Sipho Kabane, the Registrar and Chief Executive at the Council for Medical Schemes is now available. They discuss various issues including the role of the CMS and its function to assure affordable medical schemes, the delay in more affordable cover in low-income families as well as the role of medical schemes once NHI is implemented in South Africa.
Follow the below link for the recorded interview.
Recent Posts
Cemiplimab Cervical Cancer Access Navigating Treatment and Value
Cemiplimab Cervical Cancer Access has been endorsed by NICE for adults with recurrent or metastatic cervical cancer that has progressed after platinum-based chemotherapy, provided patients have not previously received immunotherapy. The final draft guidance confirms that this PD-1 inhibitor deliv...
Shifting Perspectives on Pharmaceutical Innovation ROI as Socioeconomic Investment
Pharmaceutical innovation ROI is shifting from a narrow budget metric to a powerful indicator of societal return. Between 2014 and 2024, a 3.1-year rise in utilization-weighted mean drug vintage across 29 European countries prevented 1.83 million years of life lost before age 85 and saved 20.9 mi...
Pharmaceutical Innovation Benefits Driving Socioeconomic Returns in Europe
Pharmaceutical innovation benefits extend well beyond clinical gains, delivering €5.67 in socioeconomic value for every additional euro spent on newer therapies across 29 European countries from 2014 to 2024. By reducing premature mortality, cutting hospital stays, and increasing workforce partic...